Delonix Bioworks
PrivateLast Round
Seed
Mar 11, 2021
Total Funding Raised
$14M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Delonix Bioworks is a biotechnology company that develops next-generation genetically engineered bacterial vaccines using its proprietary OMV Plus platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Delonix Bioworks Comparables
Compare Delonix Bioworks with similar companies based on industry and business-model similarity.
Delonix Bioworks Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 11, 2021 |
Delonix Bioworks Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Seed |
| ZhenFund | Seed |
| Boehringer Ingelheim Venture Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 50% MoM, from 718 to 1.1K.
- Aug 8, 2025
Collaborating with Olymvax to accelerate next-generation pertussis vaccines.
Delonix Bioworks Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Delonix Bioworks's valuation, stock price, and market status.
Is Delonix Bioworks a public or private company?
Delonix Bioworks is a private company.
What is the current stock price of Delonix Bioworks?
Delonix Bioworks is a private company with no public stock price. No recent secondary market data is available.
How much is Delonix Bioworks worth (valuation)?
Valuation information for Delonix Bioworks is not publicly available.
Can I buy Delonix Bioworks stock?
Delonix Bioworks shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Delonix Bioworks's last funding round?
Delonix Bioworks's most recent funding round was Seed on March 11, 2021.
Who are the main investors in Delonix Bioworks?
Key investors in Delonix Bioworks include IDG Capital, Boehringer Ingelheim Venture Fund.
Will Delonix Bioworks IPO soon?
No public IPO plans have been announced for Delonix Bioworks.
How can I track Delonix Bioworks secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Delonix Bioworks's secondary market activity and sign up for updates.